Century Therapeutics, Inc.

NASDAQ:IPSC

Biotechnology

Healthcare
$1.32 +0.48%

+$0.01 today

Market cap
$239.71M
Beta
1.57
P/E (TTM)
-1.8
EPS (TTM)
-$1.25
52W Low $0.44High $3.04

Volume 0.82M

Average 1.12M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$103.88M

FY 2025 · Annual

Investing Cash Flow

$107.50M

FY 2025 · Annual

+126.4% YoY

Financing Cash Flow

$173,000.00

FY 2025 · Annual

-99.8% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(95.82M)(130.93M)(136.67M)(126.57M)(9.58M)
Depreciation & Amortization3.75M8.44M13.04M13.3M13.1M
Deferred Income Tax000870K(73K)
Stock-Based Compensation4.66M10.67M14.62M12.69M6.84M
Change in Working Capital(2.8M)123.95M9.38M(9.28M)(114.55M)
Accounts Receivables00000
Inventory00000
Accounts Payables(1.85M)(4.79M)(2.36M)(1.47M)1.56M
Other Working Capital(949K)128.73M11.74M(7.81M)(116.12M)
Other Non-Cash Items1.21M1.93M11.28M(1.15M)389K
Operating Cash Flow(89M)14.05M(88.35M)(110.14M)(103.88M)
Capital Expenditures(44.97M)(30.6M)(13.74M)(154K)(848K)
Acquisitions (Net)0(238.22M)0(9.61M)0
Purchases of Investments(330.03M)(254M)(209.03M)(119.55M)(51.17M)
Sales of Investments76.67M271.48M283.9M176.79M(51.17M)
Other Investing Activities0238.22M00210.7M
Investing Cash Flow(298.34M)(13.13M)61.13M47.48M107.5M
Debt Repayment00(10.24M)00
Common Stock Issued221.62M27.16M516K74.56M173K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities36.53M0000
Financing Cash Flow417.77M27.16M(9.73M)74.56M173K
Effect of Forex Changes00000
Net Change in Cash30.43M28.08M(36.94M)11.91M3.8M
Free Cash Flow(133.97M)(16.55M)(102.08M)(110.29M)(104.72M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$9.6M
+ D&A$13.1M
+ Stock-Based Comp$6.8M
- Deferred Tax-$73.0K
- Working Capital-$114.6M
+ Other Non-Cash$389.0K
= Operating Cash Flow-$103.9M
- Capex-$848.0K
= Free Cash Flow-$104.7M

Analysis

FY2025 free cash flow is -$104.7M. FCF conversion is 1093.2% of net income. Operating cash flow was -$103.9M, with capex of -$848.0K. The largest bridge item is Working Capital at -$114.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
8-KCurrent reportOct 2, 2026
4Statement of changes in beneficial ownershipSep 15, 2026

Does IPSC generate free cash flow?

Century Therapeutics, Inc. (IPSC) generated -$104.72M of free cash flow in fiscal 2025.

How much operating cash flow does IPSC produce?

Operating cash flow was -$103.88M, before capital expenditures of $848,000.00.